BioPraxTM

Description

Currently under investigation to study the elimination of
biofilm infections on prosthetic knee implants during early intervention
procedures while maintaining the current standard of care.

  • Granted
    FDA Breakthrough Device Designation for products that may provide more
    effective treatment or diagnosis of life-threatening or irreversibly
    debilitating diseases or conditions
  • In
    vivo 
    animal and in vitro lab studies
    demonstrated up to 99.6% effectiveness in killing biofilms, including drug-resistant
    bacteria such as MRSA, E. Coli, etc.
  • May
    help retain the original implant
  • BioPrax
    is easy to use – requires minimal training
  • Minimally
    invasive procedure
×